Abstract
A guidance on the assessment and treatment of postmenopausal women at risk from fractures due to osteoporosis was recently published in Osteoporosis International as a joint effort of the International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (Kanis et al. Osteoporos Int, https://doi.org/10.1007/s00198-018-4704-5, 2018). This manuscript updates the previous guideline document, published in 2013 (Kanis et al. Osteoporos Int 24:23–57, 2013) and is written from a European perspective. The present article reports and summarizes the main recommendations included in this 2018 guidance document (Fig. 1).
Similar content being viewed by others
References
Kanis JA, Cooper C, Rizzoli R et al (2018) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. https://doi.org/10.1007/s00198-018-4704-5
Kanis JA, McCloskey EV, Johansson H et al (2013). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24:23–57
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interests
JAK reports grants from Amgen, Eli Lilly and Radius Health; non-financial support from Medimaps, and Asahi; and other support from AgNovos. JAK is the architect of FRAX® but has no financial interest. CC reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. RR has received consulting fees or advisory board fees from Radius Health, Labatec, Danone, Nestlé, CNIEL and Sandoz. J-YR has received advisory board or consulting fees from IBSA-Genévrier, Pierre Fabre, Radius Health, TEVA and Mylan; and lecture fees from Anovos, IBSA-Genévrier, Mylan, CNIEL, Dairy Research Council (DRC) and Theramex; and institutional grant support from IBSA-Genévrier, Mylan, CNIEL and Radius Health.
Statement of human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study, formal consent is not required.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reprinted by permission from Springer Nature Customer Service Centre Gmbh: Springer, Osteoporosis International, European guidance for the diagnosis and management of osteoporosis in postmenopausal women, A. Kanis, C. Cooper, R. Rizzoli, J.-Y. Reginster, 2018.
This article is co-published in the journals Aging Clinical and Experimental Research and Calcified Tissue International. https://doi.org/10.1007/s40520-018-1109-4 or https://doi.org/10.1007/s00223-018-00512-x.
Rights and permissions
About this article
Cite this article
Kanis, J.A., Cooper, C., Rizzoli, R. et al. Executive summary of European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Aging Clin Exp Res 31, 15–17 (2019). https://doi.org/10.1007/s40520-018-1109-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-018-1109-4